| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 5 | 2024 | 147 | 3.230 |
Why?
|
| Osteoblasts | 3 | 2024 | 151 | 1.330 |
Why?
|
| Intellectual Disability | 5 | 2021 | 1011 | 1.100 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 83 | 0.890 |
Why?
|
| MAP Kinase Signaling System | 2 | 2024 | 320 | 0.850 |
Why?
|
| Osteogenesis | 4 | 2024 | 154 | 0.850 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 14 | 0.770 |
Why?
|
| Coatomer Protein | 1 | 2021 | 30 | 0.760 |
Why?
|
| Hand Deformities, Congenital | 2 | 2021 | 87 | 0.730 |
Why?
|
| Osteoporosis | 1 | 2021 | 114 | 0.710 |
Why?
|
| Citrullinemia | 1 | 2020 | 15 | 0.710 |
Why?
|
| Cell Differentiation | 4 | 2024 | 1935 | 0.690 |
Why?
|
| Actins | 3 | 2021 | 339 | 0.680 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 682 | 0.680 |
Why?
|
| Bone and Bones | 1 | 2021 | 261 | 0.660 |
Why?
|
| Endocrinology | 1 | 2020 | 139 | 0.600 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 212 | 0.550 |
Why?
|
| Bone Resorption | 1 | 2016 | 41 | 0.550 |
Why?
|
| Mutation, Missense | 2 | 2018 | 826 | 0.530 |
Why?
|
| DNA-Binding Proteins | 4 | 2023 | 2029 | 0.530 |
Why?
|
| Stromal Cells | 3 | 2006 | 296 | 0.500 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4282 | 0.480 |
Why?
|
| Mutation | 9 | 2024 | 5734 | 0.470 |
Why?
|
| Mice | 10 | 2024 | 17546 | 0.390 |
Why?
|
| Animals | 15 | 2024 | 33721 | 0.380 |
Why?
|
| Micrognathism | 2 | 2021 | 64 | 0.330 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2441 | 0.330 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 738 | 0.310 |
Why?
|
| Arginine | 2 | 2020 | 302 | 0.300 |
Why?
|
| Trans-Activators | 2 | 2015 | 804 | 0.300 |
Why?
|
| Fractures, Bone | 2 | 2020 | 180 | 0.280 |
Why?
|
| Bone Marrow Cells | 3 | 2005 | 261 | 0.270 |
Why?
|
| Humans | 30 | 2024 | 122296 | 0.260 |
Why?
|
| Whole Genome Sequencing | 4 | 2024 | 279 | 0.250 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 63 | 0.240 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 17 | 0.240 |
Why?
|
| Chromosome Inversion | 1 | 2024 | 76 | 0.240 |
Why?
|
| Membrane Proteins | 3 | 2024 | 1520 | 0.230 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 92 | 0.220 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 145 | 0.220 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2023 | 18 | 0.220 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 123 | 0.220 |
Why?
|
| DNA Helicases | 3 | 2017 | 223 | 0.220 |
Why?
|
| Glycine | 1 | 2024 | 167 | 0.210 |
Why?
|
| Water | 1 | 2024 | 181 | 0.210 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 16 | 0.200 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 220 | 0.200 |
Why?
|
| Male | 15 | 2024 | 59522 | 0.200 |
Why?
|
| Stem Cells | 2 | 2024 | 710 | 0.200 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2022 | 3050 | 0.200 |
Why?
|
| Exome | 4 | 2021 | 1009 | 0.190 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 340 | 0.190 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 78 | 0.190 |
Why?
|
| Aniridia | 1 | 2021 | 12 | 0.190 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 92 | 0.190 |
Why?
|
| Down-Regulation | 1 | 2023 | 702 | 0.190 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 35 | 0.190 |
Why?
|
| Collagen Type I | 1 | 2021 | 110 | 0.190 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 141 | 0.190 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 428 | 0.180 |
Why?
|
| Transition to Adult Care | 1 | 2023 | 119 | 0.180 |
Why?
|
| Child | 9 | 2023 | 24064 | 0.180 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 1003 | 0.180 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 63 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2023 | 1015 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 213 | 0.180 |
Why?
|
| Introns | 1 | 2021 | 303 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 227 | 0.170 |
Why?
|
| Proteomics | 1 | 2023 | 475 | 0.170 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 245 | 0.170 |
Why?
|
| Ammonia | 1 | 2020 | 68 | 0.170 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2020 | 32 | 0.170 |
Why?
|
| Genome, Human | 2 | 2024 | 1248 | 0.170 |
Why?
|
| Hypothermia | 1 | 2020 | 51 | 0.170 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 27 | 0.170 |
Why?
|
| Transcription Factors | 5 | 2023 | 2578 | 0.170 |
Why?
|
| Diphosphonates | 1 | 2019 | 38 | 0.170 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2022 | 437 | 0.170 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 369 | 0.170 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 101 | 0.170 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 663 | 0.160 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2024 | 542 | 0.160 |
Why?
|
| Diet, Protein-Restricted | 1 | 2020 | 82 | 0.160 |
Why?
|
| Carboxypeptidases | 1 | 2018 | 16 | 0.160 |
Why?
|
| Mediator Complex | 1 | 2019 | 52 | 0.160 |
Why?
|
| Zebrafish | 1 | 2021 | 369 | 0.160 |
Why?
|
| Autistic Disorder | 1 | 2022 | 339 | 0.160 |
Why?
|
| Protein Binding | 2 | 2017 | 1732 | 0.160 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2018 | 63 | 0.160 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.160 |
Why?
|
| Exons | 2 | 2020 | 793 | 0.160 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 83 | 0.160 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 387 | 0.160 |
Why?
|
| Abnormalities, Multiple | 2 | 2021 | 962 | 0.160 |
Why?
|
| Heterozygote | 2 | 2017 | 675 | 0.150 |
Why?
|
| Neonatal Screening | 2 | 2017 | 187 | 0.150 |
Why?
|
| Multiple Carboxylase Deficiency | 1 | 2018 | 3 | 0.150 |
Why?
|
| Motor Neurons | 1 | 2018 | 138 | 0.150 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 21 | 0.150 |
Why?
|
| Spine | 1 | 2018 | 145 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2023 | 4511 | 0.150 |
Why?
|
| Female | 12 | 2024 | 64883 | 0.150 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2017 | 6 | 0.150 |
Why?
|
| Homocystinuria | 1 | 2017 | 21 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2020 | 8096 | 0.140 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 39 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 352 | 0.140 |
Why?
|
| Drosophila | 1 | 2022 | 765 | 0.140 |
Why?
|
| Purkinje Cells | 1 | 2018 | 156 | 0.140 |
Why?
|
| Child, Preschool | 7 | 2021 | 13777 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2021 | 878 | 0.140 |
Why?
|
| Anabolic Agents | 1 | 2016 | 13 | 0.140 |
Why?
|
| Cell Transplantation | 1 | 2016 | 54 | 0.140 |
Why?
|
| Biological Therapy | 1 | 2016 | 20 | 0.140 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 120 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 523 | 0.140 |
Why?
|
| Phenotype | 6 | 2023 | 4151 | 0.130 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2016 | 6 | 0.130 |
Why?
|
| Drug Therapy | 1 | 2016 | 87 | 0.130 |
Why?
|
| Lung | 1 | 2024 | 1476 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 207 | 0.130 |
Why?
|
| Face | 1 | 2017 | 178 | 0.130 |
Why?
|
| DNA, Ribosomal | 1 | 2015 | 55 | 0.130 |
Why?
|
| Moyamoya Disease | 1 | 2016 | 38 | 0.130 |
Why?
|
| Esophageal Achalasia | 1 | 2016 | 36 | 0.130 |
Why?
|
| Cerebellum | 1 | 2018 | 408 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 867 | 0.120 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1871 | 0.120 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 174 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2017 | 415 | 0.120 |
Why?
|
| Genetic Testing | 2 | 2018 | 978 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 431 | 0.110 |
Why?
|
| Disease Management | 1 | 2017 | 511 | 0.110 |
Why?
|
| Kidney | 1 | 2020 | 1340 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2817 | 0.110 |
Why?
|
| Albuterol | 1 | 2013 | 52 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2016 | 438 | 0.110 |
Why?
|
| Proteoglycans | 2 | 2005 | 93 | 0.100 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 62 | 0.100 |
Why?
|
| Drug Overdose | 1 | 2013 | 65 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 928 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2016 | 706 | 0.100 |
Why?
|
| Cell Survival | 2 | 2024 | 816 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 1277 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2017 | 1462 | 0.090 |
Why?
|
| Adolescent | 6 | 2019 | 18940 | 0.090 |
Why?
|
| Brain | 1 | 2021 | 2937 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 792 | 0.080 |
Why?
|
| Biglycan | 2 | 2005 | 7 | 0.070 |
Why?
|
| Hypertension | 1 | 2016 | 1274 | 0.070 |
Why?
|
| Antigens, Surface | 2 | 2005 | 122 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2005 | 148 | 0.070 |
Why?
|
| Amino Acids | 2 | 2020 | 660 | 0.070 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2006 | 123 | 0.060 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2005 | 2 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2024 | 15853 | 0.060 |
Why?
|
| Bone Matrix | 1 | 2005 | 8 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 203 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 48 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 70 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2005 | 41 | 0.060 |
Why?
|
| Osteopontin | 1 | 2005 | 49 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 96 | 0.060 |
Why?
|
| Young Adult | 4 | 2019 | 8760 | 0.060 |
Why?
|
| Alleles | 2 | 2021 | 1579 | 0.060 |
Why?
|
| Infant | 5 | 2018 | 12302 | 0.060 |
Why?
|
| Hyaluronan Receptors | 2 | 2002 | 66 | 0.060 |
Why?
|
| Therapeutic Irrigation | 1 | 2024 | 43 | 0.060 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 33 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2024 | 67 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2005 | 321 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2023 | 3770 | 0.060 |
Why?
|
| Urethra | 1 | 2024 | 81 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2018 | 4643 | 0.060 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 24 | 0.060 |
Why?
|
| Cystectomy | 1 | 2024 | 152 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2005 | 241 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 2534 | 0.050 |
Why?
|
| Adult | 6 | 2023 | 28733 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2006 | 3074 | 0.050 |
Why?
|
| Genotype | 2 | 2019 | 2525 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1710 | 0.050 |
Why?
|
| Machine Learning | 1 | 2023 | 207 | 0.050 |
Why?
|
| Facies | 1 | 2021 | 149 | 0.050 |
Why?
|
| Symptom Assessment | 1 | 2021 | 96 | 0.050 |
Why?
|
| DNA | 1 | 2006 | 1606 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 78 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3657 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2782 | 0.040 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2018 | 4 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 143 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 172 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2019 | 241 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 500 | 0.040 |
Why?
|
| Osteosarcoma | 1 | 2001 | 258 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 176 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1118 | 0.040 |
Why?
|
| Hydroxocobalamin | 1 | 2017 | 9 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2018 | 72 | 0.040 |
Why?
|
| Carnitine | 1 | 2018 | 78 | 0.040 |
Why?
|
| Colon | 1 | 2019 | 348 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2019 | 523 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3290 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 356 | 0.030 |
Why?
|
| Algorithms | 1 | 2023 | 1575 | 0.030 |
Why?
|
| Sf9 Cells | 1 | 2016 | 9 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2001 | 428 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 48 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 178 | 0.030 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2015 | 18 | 0.030 |
Why?
|
| RNA Polymerase I | 1 | 2015 | 11 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 521 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 2015 | 56 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 270 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 276 | 0.030 |
Why?
|
| COS Cells | 1 | 2015 | 273 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 798 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 384 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 137 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 594 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 546 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 541 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4366 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 755 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1533 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 348 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3626 | 0.030 |
Why?
|
| Hypokalemia | 1 | 2013 | 41 | 0.030 |
Why?
|
| Chromatin | 1 | 2015 | 552 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2002 | 63 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2013 | 221 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 668 | 0.020 |
Why?
|
| Middle Aged | 2 | 2024 | 25640 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 3448 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5013 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 2933 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 1799 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 18785 | 0.020 |
Why?
|
| Integrin alphaV | 1 | 2002 | 3 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2002 | 16 | 0.010 |
Why?
|
| L-Selectin | 1 | 2002 | 21 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2002 | 27 | 0.010 |
Why?
|
| S Phase | 1 | 2002 | 73 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2002 | 107 | 0.010 |
Why?
|
| G1 Phase | 1 | 2002 | 67 | 0.010 |
Why?
|
| P-Selectin | 1 | 2002 | 77 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2002 | 54 | 0.010 |
Why?
|
| United States | 1 | 2016 | 10487 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 400 | 0.010 |
Why?
|
| Osteoma, Osteoid | 1 | 2001 | 4 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 330 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 795 | 0.010 |
Why?
|
| Mitosis | 1 | 2001 | 239 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 230 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 810 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1076 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2826 | 0.010 |
Why?
|